An Investigation through the Pharmacotechnical Factors-to Develop a Method to Replace a Super Disintegrant in an Immediate Release Tablet

被引:0
作者
Joseph, Dhanish [1 ]
Suseem, S. R. [2 ]
机构
[1] Nirmala Coll Pharm, Dept Pharmaceut, Ernakulam, Kerala, India
[2] Vellore Inst Technol, Sch Adv Sci, Dept Chem, Vellore 632014, Tamil Nadu, India
关键词
Disintegration Time; Potent Drug; Dissolution enhancement; Design Expert; Compressibility Index; Particle Size and Hardness; GRANULE PROPERTIES; WET GRANULATION; FORMULATION;
D O I
10.5330/ijpi.2019.4.31
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Objectives: The present work aim to identify the process parameters and technical parameters of granules that affect the disintegration time of an IR tablet. There by utilizing this knowledge to develop an IR tablet without any Super Disintegrants (SD). Methods: The experiments were designed using Design-Expert (R). A two factorial design at two levels (-1, + 1) were selected. The study evaluated the effect of particle size and Binder concentration (BC) on Disintegration Time (DT), Hardness and Compressibility index (CI). Discussion: The CI below 16% can be achieved for the granules prepared with particle size > 67 mu m and binder concentration> 18.56mg for PVP K 30. The particle sizes do not possess any impact on disintegration time. The granules prepared at the 250 mu size and 600 mu size shoes similar disintegration time. However, the particle size affects hardness and CI. The BC has a strong impact on hardness, CI and DT. Even though the particle size does not have a direct impact on DT, it affects the hardness, which has a greater impact on DT. Conclusion: The study identified the technical methods and suggests certain formula to attain the low disintegration time, excellent hardness for an IR tablet and fair flow property for the prepared granules. The particle size has a direct impact on the hardness of the tablet. The formula serves as an excellent alternative for SD at an industrial level, to make the drug product more economical and more effective.
引用
收藏
页码:164 / 168
页数:5
相关论文
共 25 条
[1]   Tablet fragmentation without a disintegrant: A novel design approach for accelerating disintegration and drug release from 3D printed cellulosic tablets [J].
Arafat, Basel ;
Wojsz, Magdalena ;
Isreb, Abdullah ;
Forbes, Robert T. ;
Isreb, Mohammad ;
Ahmed, Waqar ;
Arafat, Tawfiq ;
Alhnan, Mohamed A. .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2018, 118 :191-199
[2]   The technologies used for developing orally disintegrating tablets: A review [J].
Badgujar, Bhatu P. ;
Mundada, Atish S. .
ACTA PHARMACEUTICA, 2011, 61 (02) :117-139
[3]  
BANDARI S, 2014, ASIAN J PHARM SCI, V2, P1
[4]   Formulation and in vitro evaluation of theophylline matrix tablets prepared by direct compression: Effect of polymer blends [J].
El-Bagory, Ibrahim ;
Barakat, Nahla ;
Ibrahim, Mohamed A. ;
El-Enazi, Fouza .
SAUDI PHARMACEUTICAL JOURNAL, 2012, 20 (03) :229-238
[5]   Tablet formulation containing meloxicam and β-cyclodextrin:: Mechanical characterization and Bioavailability evaluation -: art. no. 59 [J].
Ghorab, MM ;
Abdel-Salam, HM ;
El-Sayad, MA ;
Mekhel, MM .
AAPS PHARMSCITECH, 2004, 5 (04)
[6]   Development and evaluation of orally disintegrating tablets (ODTs) containing Ibuprofen granules prepared by hot melt extrusion [J].
Gryczke, Andreas ;
Schminke, Silke ;
Maniruzzaman, Mohammed ;
Beck, Julien ;
Douroumis, Dennis .
COLLOIDS AND SURFACES B-BIOINTERFACES, 2011, 86 (02) :275-284
[7]   Toward a Quality-of-Service Framework for Peer-to-Peer Applications [J].
Gupta, Ankur ;
Awasthi, Lalit K. .
INTERNATIONAL JOURNAL OF DISTRIBUTED SYSTEMS AND TECHNOLOGIES, 2010, 1 (03) :1-23
[8]   Development of fast dispersing tablets of nebivolol: experimental and computational approaches to study formulation characteristics [J].
Jayaramu, Rajamma Abburu ;
Boregowda, Sateesha Shivally ;
Varma, Addanki Rahul Deva ;
Kalegowda, Chandan .
BRAZILIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2014, 50 (04) :955-963
[9]   Rheological properties of dense granular flows [J].
Jop, Pierre .
COMPTES RENDUS PHYSIQUE, 2015, 16 (01) :62-72
[10]  
Kaur A, 2017, INT J DRUG RES TECHN, V5, P11